期刊文献+

PPARα、PPARγ在左卡尼汀改善结肠癌小鼠恶病质中的作用 被引量:2

L-carnitine Ameliorates Colonic Cancer Cachexia in Mice by Regulating the Expressions of PPARα and PPARγ
暂未订购
导出
摘要 背景:左卡尼汀(LC)改善恶病质的作用已日渐受到关注。目的:探讨PPARα、PPARγ在LC改善结肠癌小鼠恶病质中的作用。方法:建立结肠癌小鼠恶病质模型,并分为LC组、左卡尼汀棕榈酸酰基转移酶(CPT)抑制剂(ILC)组、阴性对照组(NST),另设立正常对照组(NTB)。实验第19 d处死所有小鼠。测定小鼠体质量、去瘤体质量、摄食量,以全自动生化仪检测血清白蛋白、血糖、胆固醇含量,ELISA法检测血清TNF-α、IL-6含量,实时定量PCR和蛋白质印迹法分别检测肝组织PPARα、PPARγmRNA和蛋白表达。结果:与NST组、ILC组相比,LC组小鼠体质量、去瘤体质量、摄食量、血清白蛋白、血糖均显著升高(P<0.05),血清胆固醇、TNF-α、IL-6含量均显著降低(P<0.05),PPARα、PPARγmRNA和蛋白表达均显著升高(P<0.05)。结论:PPARα、PPARγ可能参与结肠癌小鼠恶病质的发生;LC可能通过PPARα、PPARγ相关肝脏脂质代谢信号通路来改善肿瘤恶病质。 Background: The role of L-carnitine (LC) in ameliorating cachexia has been focused on increasingly in recent years. Aims: To investigate the role of PPARα, PPARy in ameliorating colonic cancer cachexia by LC in mice. Methods: Colonic cancer cachexia model was established in mice. Mice were randomly divided into tumor bearing group treated with LC ( LC group) , tumor bearing group treated with LC palmitoyl-transferase (CFF) inhibitor ( ILC group) , tumor bearing group treated with normal saline ( NST group) , and non-tumor bearing mice were served as normal controls ( NTB group). On the 19'h day, all the mice were sacrificed. Body weight, tumor-free body weight, food consumption were measured. Serum levels of albumin, glucose, cholesterol were determined by automatic biochemistry analyzer. ELISA assay was used to detect serum levels of TNF-α and IL-6. mRNA and protein expressions of PPARα, PPARy in liver tissue were determined by real time quantitive PCR and Western blotting, respectively. Results: Compared with NST group and ILC group, body weight, tumor-free body weight, food consumption, serum levels of albumin and glucose in LC group were significantly increased (P 〈 0. 05 ), serum levels of cholesterol, TNF-α, IL-6 were significantly decreased ( P 〈 0. 05 ), mRNA and protein expressions of PPARα, PPARy were significantly increased ( P 〈 0.05 ). Conclusions : PPARα, PPARy may be involved in the formation of colonic cancer cachexia in mice. The ameliorating of cancer cachexia by LC may be related to the regulating of PPARα-, PPARy-related signaling pathway of hepatic lipid metabolism.
出处 《胃肠病学》 2013年第5期266-270,共5页 Chinese Journal of Gastroenterology
基金 上海市闸北区科委重点科研课题(2012ZD04)资助
关键词 结肠肿瘤 恶病质 左卡尼汀 PPARΑ PPARΓ Colonic Neoplasms Cachexia L-Carnitine PPAR alpha PPAR gamma
  • 相关文献

参考文献17

二级参考文献68

共引文献59

同被引文献33

  • 1Mariano Malaguarnera,Corrado Risino,Maria Pia Gargante,Giovanni Oreste,Gloria Barone,Anna Veronica Tomasello,Mario Costanzo,Matteo Angelo Cannizzaro.Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia[J].World Journal of Gastroenterology,2006,12(28):4541-4545. 被引量:3
  • 2Sílvia Busquets,Roberto Serpe,Míriam Toledo,Angélica Betancourt,Enrica Marmonti,Marcel Orpí,Fabrizio Pin,Eva Capdevila,Clelia Madeddu,Francisco J. López-Soriano,Giovanni Mantovani,Antonio Macciò,Josep M. Argilés.l -Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer[J].Clinical Nutrition.2012(6)
  • 3Jaros?aw Szefel,Wies?aw Kruszewski,Maciej Ciesielski,Mariusz Szajewski,Krzysztof Kawecki,Ewa Aleksandrowicz?Wrona,Jerzy Jankun,Wies?awa ?ysiak-Szyd?owska.L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolicdisorders in cancer cachexia[J].Oncology Reports.2012(1)
  • 4Kenneth Fearon,Florian Strasser,Stefan D Anker,Ingvar Bosaeus,Eduardo Bruera,Robin L Fainsinger,Aminah Jatoi,Charles Loprinzi,Neil MacDonald,Giovanni Mantovani,Mellar Davis,Maurizio Muscaritoli,Faith Ottery,Lukas Radbruch,Paula Ravasco,Declan Walsh,Andrew Wilcock,Stein Kaasa,Vickie E Baracos.Definition and classification of cancer cachexia: an international consensus[J].Lancet Oncology.2011(5)
  • 5N. Johns,N.A. Stephens,K.C.H. Fearon.??Muscle wasting in cancer(J)International Journal of Biochemistry and Cell Biology . 2013
  • 6Cachexia in pancreatic cancer – Mechanisms and potential intervention(J)e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism . 2009 (6)
  • 7Argiles JM,Busquets S,Stemmler B,et al.Cancer cachexia:understanding the molecular basis. Nature Reviews Cancer . 2014
  • 8von Haehling Stephan,Anker Stefan D.Cachexia as a major underestimated and unmet medical need: facts and numbers. Journal of cachexia, sarcopenia and muscle . 2011
  • 9Luigi G Spagnoli,Giampiero Palmieri,Alessandro Mauriello,Gian Maria Vacha,Stefania D’Iddio,Giovanni Giorcelli,Marco Corsi.Morphometric Evidence of the Trophic Effect of L-Carnitine on Human Skeletal Muscle. Nephron . 1990
  • 10Giovenali P,Fenocchio D,Montanari G,Cancellotti C,D’Iddio S,Buoncristiani U,Pelagaggia M,Ribacchi R.Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Kidney International . 1994

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部